Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Antisense Therapeutics Limited (AU:ANP)
ASX:ANP
RESEARCH TOOLSreports
Antisense Therapeutics Limited (ANP) Ownership - Who Owns Antisense Therapeutics Limited?
2 Followers
Antisense Therapeutics Limited (ANP) Ownership Overview
2.34% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
97.66% Public Companies and
Individual Investors
The ownership structure of Antisense Therapeutics Limited (AU:ANP) stock is a mix of institutional, retail and individual investors. Approximately 0.00% of the company’s stock is owned by Institutional Investors, 2.34% is owned by Insiders and 97.66% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 20, 2023 | James Garner Chief Executive & Managing Director | Bought | AU$6100 |
| Oct 02, 2023 | Ben Gil Price Non Executive,director | Bought | AU$28400 |
| Aug 22, 2023 | James Garner Chief Executive & Managing Director | Bought | AU$30000 |
| Aug 22, 2023 | Charmaine Gittleson Chairman | Bought | AU$30000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,090,201 | Insider | 1.01% | 554,502 | |
| 4,893,722 | Insider | 0.54% | 298,517 | |
| 2,568,750 | Insider | 0.28% | 156,694 | |
| 1,099,243 | Insider | 0.12% | 67,054 | |
| 1,000,000 | Insider | 0.11% | 61,000 | |
| 999,805 | Insider | 0.11% | 60,988 | |
| 733,333 | Insider | 0.08% | 44,733 | |
| 395,550 | Insider | 0.04% | 24,129 | |
| 285,579 | Insider | 0.03% | 17,420 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Antisense Therapeutics Limited (AU:ANP)?
According to the latest TipRanks data, approximately 0.00% of the company's stock is held by institutional investors, 2.34% is held by insiders, and 97.66% is held by retail investors.
What percentage of Antisense Therapeutics Limited (AU:ANP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.00% of Antisense Therapeutics Limited (AU:ANP) stock is held by institutional investors.
What percentage of Antisense Therapeutics Limited (AU:ANP) stock is held by retail investors?
According to the latest TipRanks data, approximately 97.66% of Antisense Therapeutics Limited (AU:ANP) stock is held by retail investors.
Who owns the most shares of Antisense Therapeutics Limited (AU:ANP)?
Robert W Moses owns the most shares of Antisense Therapeutics Limited (AU:ANP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.